Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

AIDS

Volumn 14, Issue 13, 2000, Pages 1985-1991

  Girardi, Enrico ^a   Antonucci, Giorgio ^a   Vanacore, Paola ^a   Libanore, Marco ^b   Errante, Isabella ^c   Matteelli, Alberto ^d   Ippolito, Giuseppe ^e  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d Divisione di Malattie Infettive   (Italy)

^e NONE

Author keywords

Antiretroviral therapy; Cohort study; Combination therapy; HIV infection; Tuberculin reactivity; Turberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0034622964     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200009080-00015     Document Type: Article

References (23)

1. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
3. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
4. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997
5. Feasibility of preventive therapy of tuberculosis in HIV-infected subjects - GISTA Study
6. Linee-guida per la chemioterapia preventiva della tubercolosi nei soggetti con infezione da HIV in Italia
7. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescent and adults
8. Diagnostic standards and classification of tuberculosis
9. Zidovudine, didanosine and zalcitabine in the treatment of HIV infection: Meta-analyses of the randomized evidence
10. Treatment with lamivudine, zidovudine or both in HIV- positive patients with 200-500 CD4 cells per cubic millimeter
11. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
12. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection
13. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study
14. Incidence of tuberculosis in the United States among HIV-infected persons
15. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial
16. Changes in use of antiretroviral therapy in regions of Europe over time
17. National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome
18. Tuberculosis morbidity - United States 1997
19. Predictors of long term response to protease inhibitor therapy in a cohort HIV-infected patients
20. Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment
21. HIV-1 RNA, CD4 cell count and the risk of progression to AIDS and death during treatment with HIV-1 reverse transcriptase inhibitors
22. Tuberculosis elimination revisited: Obstacles, opportunities, and a renewed commitment - Advisory Council for the Elimination of Tuberculosis (ACET)